1. 1) Bartlett J. G., Chang T. W., Gurwith M., Gorbach S. L., Onderdonk A. B., N. Engl. J. Med., 298, 531–534 (1978).
2. 2) Committee for the Development of Guidelines for Clostridioides difficile Infection Control, Japan Society of Environmental Infectious Diseases. Jpn. J. Environ. Infect., 37, Suppl. II (2022).
3. 3) Committee for the Preparation of Guidelines for the Diagnosis and Treatment of CDI Infections, The Japanese Society for Chemotherapy and The Japanese Society of Infectious Diseases. Jpn. J. Chemother., 71, 1–90 (2023).
4. 4) Sørensen C. G., Karlsson W. K., Amin F. M., Lindelof M., J. Neurol., 267, 1–13 (2020).
5. 5) Kikuchi K., Hashimoto M., “Nihongoban The Sanford Guide to Antimicrobial Therapy 2022,” 52nd ed., Life Science Publishing Company, Tokyo, 2022.